Japan Life Sciences Bpo Market Size & Outlook, 2023-2030
Japan life sciences bpo market, 2018-2030 (US$M)
Related Markets
Japan life sciences bpo market highlights
- The Japan life sciences bpo market generated a revenue of USD 29,043.7 million in 2023 and is expected to reach USD 57,903.6 million by 2030.
- The Japan market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, pharmaceutical outsourcing was the largest revenue generating services in 2023.
- Medical devices outsourcing is the most lucrative services segment registering the fastest growth during the forecast period.
Life sciences bpo market data book summary
| Market revenue in 2023 | USD 29,043.7 million |
| Market revenue in 2030 | USD 57,903.6 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical outsourcing |
| Fastest growing segment | Medical devices outsourcing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical outsourcing, Medical devices outsourcing, Contract sales and marketing outsourcing |
| Key market players worldwide | Atos SE, Boehringer Ingelheim, Catalent Inc, Labcorp Drug Development, Genpact Ltd, Icon PLC, Infosys Ltd ADR, International Business Machines Corp, Lonza Group Ltd, PAREXEL, IQVIA Holdings Inc |
Other key industry trends
- In terms of revenue, Japan accounted for 6.5% of the global life sciences bpo market in 2023.
- Country-wise, India is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, India life sciences bpo market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 143,559.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Life Sciences BPO Market Scope
Life Sciences BPO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan life sciences bpo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to life sciences bpo market will help companies and investors design strategic landscapes.
Pharmaceutical outsourcing was the largest segment with a revenue share of 55.13% in 2023. Horizon Databook has segmented the Japan life sciences bpo market based on pharmaceutical outsourcing, medical devices outsourcing, contract sales and marketing outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
- Japan Life Sciences BPO Services Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical outsourcing
- Contract Manufacturing Market
- API
- Finished Dose Form
- Packaging
- Contract Research Organizations
- Drug Discovery
- Preclinical Studies
- Clinical Trial Studies
- Regulatory Services
- Pharmacovigilance
- Contract Manufacturing Market
- Medical devices outsourcing
- Contract Manufacturing Market
- Electronic Manufacturing Services
- Finished Goods
- Raw Materials/ Components
- Contract Research Organizations
- Regulatory Consulting Services
- Product Design and Development Services
- Product Testing Services
- Product Implementation Services
- Product Upgrade Services
- Product Maintenance Services
- Contract Manufacturing Market
- Contract sales and marketing outsourcing
- Others
- Pharmaceutical outsourcing
Reasons to subscribe to Japan life sciences bpo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan life sciences bpo market databook
-
Our clientele includes a mix of life sciences bpo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan life sciences bpo market, including forecasts for subscribers. This country databook contains high-level insights into Japan life sciences bpo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan life sciences bpo market size, by services, 2018-2030 (US$M)
Japan Life Sciences BPO Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
